US2003044351A1PendingUtilityA1
Standardized compositions which facilitate swallowing in dysphagic subjects
Priority: Aug 27, 1999Filed: Aug 26, 2002Published: Mar 6, 2003
Est. expiryAug 27, 2019(expired)· nominal 20-yr term from priority
Inventors:Jo Anne Robbins
A61K 49/0404A61P 1/00
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are kits containing two or more viscosity-standardized, edible solutions for evaluating human subjects for dysphagia. Also disclosed are corresponding methods of using the kits for diagnosing dysphagia and for radiographic imaging of the oropharynx.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A kit of individual viscosity-standardized edible solutions for evaluating human subjects for dysphagia, the kit comprising at least two edible solutions selected from the group consisting of:
(a) a first edible solution having a known viscosity of from about 1 cp to about 60 cp at about 23° C., the first edible solution disposed in a first container; (b) a second edible solution having a known viscosity of from about 300 cp to about 2000 cp at about 23° C., the second edible solution disposed in a second container; and (c) a third edible solution having a known viscosity equal to or greater than about 3000 cp at about 23° C., the third edible solution disposed in a third container.
2 . The kit according to claim 1 , wherein the second edible solution has a viscosity of between about 300 cp to about 500 cp.
3 . The kit according to claim 1 , wherein the second edible solution has a viscosity of between about 500 cp to about 1500 cp.
4 . The kit according to claim 1 , wherein the third edible solution has a viscosity of between about 3000 cp to about 5000 cp.
5 . The kit according to claim 1 , wherein the third edible solution has a viscosity of between about 3000 cp to about 4000 cp.
6 . The kit according to claim 1 , wherein the second edible solution has a viscosity of between about 300 cp to about 500 cp, and the third edible solution has a viscosity of between about 3000 cp to about 5000 cp.
7 . The kit according to claim 1 , wherein the second edible solution has a viscosity of between about 500 cp to about 1500 cp, and the third edible solution has a viscosity of between about 3000 cp to about 5000 cp.
8 . The kit according to claim 1 , wherein the second edible solution has a viscosity of between about 300 cp to about 500 cp, and the third edible solution has a viscosity of between about 3000 cp to about 4000 cp.
9 . The kit according to claim 1 , wherein the second edible solution has a viscosity of between about 500 cp to about 1500 cp, and the third edible solution has a viscosity of between about 3000 cp to about 4000 cp.
10 . The kit according to claim 1 , wherein the first, second, and third edible solutions comprise an imaging agent.
11 . The kit according to claim 10 , wherein the imaging agent comprises a radio-opaque imaging agent.
12 . The kit according to claim 11 , wherein the radio-opaque imaging agent comprises a barium-containing compound.
13 . The kit according to claim 11 , wherein the radio-opaque imaging agent comprises barium sulfate.
14 . A method for evaluating a human subject for dysphagia, the method comprising:
(a) providing at least two edible solutions selected from the group consisting of:
(i) a first edible solution having a known viscosity of from about 1 cp to about 60 cp at about 23° C., the first edible solution disposed in a first container;
(ii) a second edible solution having a known viscosity of from about 300 cp to about 2000 cp at about 23° C., the second edible solution disposed in a second container; and
(iii) a third edible solution having a known viscosity equal to or greater than about 3000 cp at about 23° C., the third edible solution disposed in a third container; and then
(b) (i) evaluating swallowing in the subject for indications of dysphagia during and after the subject swallows one of the edible solutions; and
(ii) evaluating swallowing in the subject for indications of dysphagia during and after the subject swallows another of the edible solutions.
15 . The method according to claim 14 , wherein in step (a) the first, second, and third edible solutions comprise a radio-opaque imaging agent that does not leave an artificial coating in the mouth and oropharynx after swallowing is complete; and in steps (b)(i) and (b)(ii), swallowing is evaluated by radiography.
16 . The method according to claim 14 , wherein the first, second, and third edible solutions comprise a non-pulpy fruit juice wherein viscosity of the fruit juice is modified by adding a thickening agent thereto.
17 . The method according to claim 16 , wherein the fruit juice is apple juice.
18 . The method according to claim 14 , wherein the first, second, and third edible solutions comprise an imaging agent.
19 . The method according to claim 18 , wherein the imaging agent comprises a radio-opaque imaging agent.
20 . The method according to claim 19 , wherein the radio-opaque imaging agent comprises a barium-containing compound.
21 . The method according to claim 19 , wherein the radio-opaque imaging agent comprises barium sulfate.
22 . A kit of compositions of matter, the compositions capable of being diluted to yield viscosity-standardized edible solutions for evaluating human subjects for dysphagia, the kit comprising at least two compositions of matter selected from the group consisting of:
(a) a first composition capable of yielding upon dilution a first edible solution having a known viscosity of from about 1 cp to about 60 cp at about 23° C.; (b) a second composition capable of yielding upon dilution a second edible solution having a known viscosity of from about 300 cp to about 2000 cp at about 23° C.; and (c) a third composition capable of yielding upon dilution a third edible solution having a known viscosity equal to or greater than about 3000 cp at about 23° C.
23 . The kit according to claim 22 , wherein the first, second, and third edible solutions comprise an imaging agent.
24 . The kit according to claim 23 , wherein the imaging agent comprises a radio-opaque imaging agent.
25 . The kit according to claim 24 , wherein the radio-opaque imaging agent comprises a barium-containing compound.
26 . The kit according to claim 24 , wherein the radio-opaque imaging agent comprises barium sulfate.Join the waitlist — get patent alerts
Track US2003044351A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.